Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 16;9(1):1102.
doi: 10.1038/s41467-018-03495-3.

Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis

Affiliations

Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis

Andrea Mencarelli et al. Nat Commun. .

Abstract

The intestinal immune system can respond to invading pathogens yet maintain immune tolerance to self-antigens and microbiota. Myeloid cells are central to these processes, but the signaling pathways that underlie tolerance versus inflammation are unclear. Here we show that mice lacking Calcineurin B in CD11chighMHCII+ cells (Cnb1 CD11c mice) spontaneously develop intestinal inflammation and are susceptible to induced colitis. In these mice, colitis is associated with expansion of T helper type 1 (Th1) and Th17 cell populations and a decrease in the number of FoxP3+ regulatory T (Treg) cells, and the pathology is linked to the inability of intestinal Cnb1-deficient CD11chighMHCII+ cells to express IL-2. Deleting IL-2 in CD11chighMHCII+ cells induces spontaneous colitis resembling human inflammatory bowel disease. Our findings identify that the calcineurin-NFAT-IL-2 pathway in myeloid cells is a critical regulator of intestinal homeostasis by influencing the balance of inflammatory and regulatory responses in the mouse intestine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Calcineurin B and NFAT expression in mouse intestinal myeloid cells. a Relative expression levels of Cnb1, Nfat1, and Nfat2 mRNAs in intestinal CD11chighMHCII+ cells (CD11b+ and CD11b) and MLN CD3+ T cells, assessed by qRT-PCR. Data represent the means ± standard error of three experiments (n ≥ 7 mice/exp). b, c Percentage of NFAT-1+ cells (b) and NFAT-1 protein levels (c) in CD11chighMHCII+ cells (CD11b+ and CD11b) obtained from spleen, MLN, PP, and colonic LP (LP-colon), assessed by flow cytometry. Splenic CD3+CD4+ T cells are included for comparison. Data represent the means ± standard error of three experiments (n = 4–5 mice/experiment). **P < 0.01 versus CD4+ T cells (ANOVA followed by Dunnett’s multiple comparisons test). d Representative images of NFAT-1 labeling in sorted colonic CD11chighMHCII+ cells (CD11b+ and CD11b). Scale bar 5 μm. e NFAT-1 nuclear translocation in CD11chighMHCII+ cells (CD11b+ and CD11b) after 30 min stimulation with thapsigargin (Thap; 200 nm), as assessed by confocal analysis. Data represent the means ± standard error of two experiments (n = 6–10 mice/experiment). Scale bar 5 μm. f NFAT-dependent luciferase activity measured in a DC cell line in response to TLRs (Poly I:C, LPS), dectin-1 ligands (PGG and WGP), and the calcium mobilizer thapsigargin. g Dose-dependent inhibition of NFAT nuclear translocation by cyclosporin A (CsA) and tacrolimus (FK506) in WGP-stimulated D1 cells, as assessed by NFAT-luciferase activity. AU arbitrary units, Ctrl control, Luc luciferase, LP lamina propria, LPS Lipopolysaccharide, MLN mesenteric lymph node, PGG soluble β-(1,3)-glucan, PP Peyer’s Patches, WGP whole glucan particles, Thap thapsigargin
Fig. 2
Fig. 2
Cnb1 deletion in CD11chighMHCII+ cells abrogates NFAT-1 nuclear translocation. a Cnb1 mRNA levels in DCs (CD11chighMHCII+CD11b+, CD11chighMHCII+CD11b) and macrophages (CD11clowMHCII+CD11b+CD64+) isolated from the LP-colon of Cnb1CD11c and Cnb1fl/fl mice, measured by qRT-PCR. Data represent the means ± standard error of three experiments (n = 3 mice/experiment). **P < 0.01. b Confocal microscopy analysis of NFAT-1 nuclear translocation in CD11chighMHCII+ cells (CD11b+ and CD11b) from the MLN of Cnb1CD11c and Cnb1fl/fl mice after thapsigargin stimulation for 30 min. Data represent the means ± standard error of two experiments (n = 3 mice/experiment). **P < 0.01. Scale bar 10 μm. c Representative flow cytometric analysis of intestinal LP mononuclear myeloid CD11c+ cells evaluated by CD11c, CD103, CD11b, and CD64 expression. Four myeloid cell subsets were identified: three DC populations, CD11chighCD103+, CD11chighCD103+CD11b+, CD11chighCD103CD11b+ and one CD11clowCD103CD11b+ macrophage population. The macrophage population was identified based on the expression of CD64 within the CD11clowCD103CD11b+ population (CD11clow CD64+). The frequency of the four different myeloid subsets in LP-colon (left) and LP-SI (right) of Cnb1CD11c and Cnb1fl/fl mice is shown. Data represent the means ± standard error of three experiments (n = 2–3 mice/group per experiment, aged 8–12 weeks). LP lamina propria, SI small intestine
Fig. 3
Fig. 3
Cnb1CD11c mice exhibit high intestinal permeability and inflammation. a MLN from Cnb1CD11c and Cnb1fl/fl mice. b Histological inflammation index of proximal (prox; n = 15–20 mice), medial (med; n = 22–27 mice), and terminal (term; n = 20–25 mice) small intestine (SI) and colon (n = 24–29 mice) in Cnb1CD11c and Cnb1fl/fl mice. *P < 0.05, ***P < 0.0001. Representative images of H&E-stained terminal ileum (SI) and colon sections from Cnb1CD11c and Cnb1fl/fl mice (×10 magnification). Scale bar 0.1 mm. c Intestinal permeability of Cnb1CD11c and Cnb1fl/fl mice was assessed by measuring the FITC-dextran concentration in the plasma after FITC-dextran administration by oral gavage (upper panel). *P < 0.05. IgA levels in the fecal content of colons from Cnb1CD11c and Cnb1fl/fl mice (lower panel). **P < 0.01. Data shown are from three independent experiments (n = 5–8 mice/group per experiment). d Myeloperoxidase, TNF, IFNγ, and IL-17 levels in terminal SI and colon tissue homogenates from Cnb1CD11c and Cnb1fl/fl mice, assessed by ELISA. Data shown are from four experiments (n = 5–6 mice/group per experiment). *P < 0.05, **P < 0.01. e Leukocyte abundance and population composition in the SI and colonic LP of Cnb1CD11c and Cnb1fl/fl mice. Data represent the mean number of CD45+ LP mononuclear cells obtained from each colon or SI, the total percentage of CD4+ T cells, the percentage of antigen-experienced CD4+ T cells (CD44highCD62Lneg), and of CD4+ T cells producing IL-17 or IFNγ. Data represent the means ± standard error of 7–9 experiments (n = 5–7 mice/group per experiment). *P < 0.05, **P < 0.01. f Percentage of FoxP3+ CD4+ T cells in the thymus, spleen, MLN, LP-colon, and LP-SI of Cnb1CD11c and Cnb1fl/fl mice. Data represent the means ± standard error of 3–6 experiments (n = 3–6 mice/group). *P < 0.05. DX4000 4 kDa dextran, FITC fluorescein isothiocyanate, LP lamina propria, MLN mesenteric lymph node, MPO myeloperoxidase
Fig. 4
Fig. 4
Exacerbation of acute and chronic colitis in Cnb1CD11c mice. a Severity of TNBS-induced colitis evaluated according to weight loss (left panel) and stool consistency (right panel) in Cnb1CD11c and Cnb1fl/fl mice. b Macroscopic index (left) and overt anatomy of the colon (right) and c histological inflammation score for colons of Cnb1CD11c and Cnb1fl/fl mice after TNBS administration. Representative H&E-stained colon sections showing infiltrating leukocytes (×10 magnification, scale bar 0.1 mm). d Levels of inflammatory markers (MPO, TNF, IL-17, and IFNγ) in total colon homogenates from Cnb1CD11c and Cnb1fl/fl mice. All data represent the means ± standard error of two experiments (n = 6–7 mice/group per experiment). *P < 0.05, ***P < 0.001. TNBS trinitrobenzenesulfonic acid, MPO myeloperoxidase
Fig. 5
Fig. 5
Calcineurin-NFAT signaling in CD11c+MHCIIhigh myeloid cells regulates IL-2 synthesis. a CD11chighMHCIIhighCD11b cells sorted from MLN of Cnb1CD11c and Cnb1fl/fl mice were stimulated with thapsigargin for 16–20 h. Cytokine levels were measured in the culture supernatants using Luminex technology. Data represent the means ± standard error of three experiments (n = 10 mice/group per experiment). *P < 0.05. b, c IL-2 production from bone marrow-derived DCs of Il2KO, Cnb1CD11c, and Cnb1fl/fl mice in response to thapsigargin stimulation for 16 h, as assessed by ELISA (b) and by intracellular labeling (c). Data represent the means ± standard error of three experiments (n = 1–2 mice/group; mice aged 6–7 weeks old). **P < 0.01, ***P < 0.001. d GFP (corresponding to IL-2) expression in CD11chighMHCII+ cells, CD3+CD4+ T cells, and total myeloid CD11b+ (CD4CD11c) cells isolated from the spleen and MLN of IL-2-GFP reporter mice. Data represent the means ± standard error of four experiments (n ≥ 3 mice/group). *P < 0.05. e Intracellular IL-2 labeling of colonic CD3CD11chighMHCII+ cells from Il2KO, Cnb1fl/fl and Cnb1CD11c mice. Data are presented as the relative percentage of IL-2+ cells and represent the means ± standard error of five experiments (n = 3–4 mice/group per experiment). **P < 0.01, ***P < 0.001. f Percentage of IL-2+ cells in intestinal DC (CD45+LinCD3CD11c+MHCII+CD24+CD64F4/80) and macrophage (CD45+LinCD3CD11c+MHCII+CD24CD64+F4/80+/−) populations in LP-colon and LP-small intestine of Cnb1fl/fl mice at steady state, or during colitis induced in immunocompromised Rag1KO mice by adoptive transfer of naïve CD4+ T cells (CD45RBhighCD62L+CD44CD25) isolated from the spleens of C57BL/6 mice. Data represent the means ± standard error of three experiments (5–6 mice/group). g IL-2 expression in CD103 and CD103+ CD11chighMHCII+ cells from colons of Cnb1fl/fl and Cnb1CD11c mice. Representative dot plots of IL-2 labeling in colonic CD3CD11chighMHCII+ cells are shown. Data represent the means ± standard error of three experiments (n = 2–5 mice/group per experiment). *P < 0.05. KO knockout, LP lamina propria, MLN mesenteric lymph node, SI small intestine, Thap thapsigargin, UT untreated, ND not detected
Fig. 6
Fig. 6
Th1/Th17-cell expansion and Treg-cell contraction in the gut of Il2CD11c mice. a Change in body weight (expressed as Δ percentage relative to the mean weight of the control group) in Il2CD11c mice compared to Il2fl/fl mice. Data represent the means ± standard error (n = 20 mice/group). *P < 0.05, **P < 0.01. b Representative images of the MLN (left) and colons (right) from Il2CD11c and Il2fl/fl mice aged 10 weeks old. c H&E staining of colon sections showing massive leukocyte infiltration in Il2CD11c compared to Il2fl/fl mice (×10 magnification, scale bar 0.1 mm). Histological inflammation index of the colon was also evaluated over time. Data represent the means ± standard error (14 mice/group aged 6–10 weeks old, and 6 mice/group aged 14–17 weeks old). ***P < 0.001. d Plasma levels of C-reactive protein (CRP) and IgG1 in the sera of Il2CD11c and Il2fl/fl mice. Data represent the means ± standard error (5–7 mice/group). **P < 0.01. e Immune phenotype of LP-colon mononuclear cells from Il2CD11c and Il2fl/fl mice. Data represent the means ± standard error of the total number of mononuclear cells obtained from the LP, the percentage of total and antigen-experienced CD44highCD62L- CD4+ T cells, and the proportion of CD4+ T cells producing IL-17, IFNγ or IL-4. f Frequency of FoxP3+ Treg cells in thymus, spleen, MLN, and LP-colon isolated from Il2CD11c and Il2fl/fl mice. Data represent the means ± standard error of 3–4 experiments (n = 2–4 mice/group per experiment, aged 6–10 weeks). **P < 0.01, ***P < 0.001. LP lamina propria, MLN mesenteric lymph node
Fig. 7
Fig. 7
DC-derived IL-2 suppresses pathogenic CD4+ T-cell expansion in the intestine. a Change in body weight and b severity of colitis based on colon length of Il2CD11c and Il2fl/fl, Rag2 knockout (KO) mice (Rag2KOIL-2fl/fl and Rag2KOIL-2CD11c mice) adoptively transferred with naïve CD4+ T cells either alone or in combination with Treg cells isolated from spleens of C57BL/6 mice. Representative pictures of colons after adoptive T-cell transfer are shown. Data represent the means ± standard error of two experiments (n = 2–5 mice/group per experiment). **P < 0.01. c Histological inflammatory score based on H&E staining of colon sections (×10 magnification, scale bar 0.5 mm) obtained from Rag2KOIl2fl/fl and Rag2KOIl2CD11c mice after 110 days of naïve CD4+ T-cell transfer. Data represent the means ± standard error. ***P < 0.001. d, e Phenotypic analysis of colonic lamina propria CD4+ T cells evaluated 110 days after adoptive T-cell transfer. The total number and the relative percentage of total and activated CD4+ T cells (d), as well as the proportions of CD4+ T cells producing IL-17, IFNγ or both (e) are shown. *P < 0.05, **P < 0.01, ***P < 0.001. All data represent the means ± standard error of two experiments (n = 3–4 mice/group per experiment)
Fig. 8
Fig. 8
Il2 or Cnb1 deficiency in DCs causes a dysregulated T-cell response. a, b Naïve congenic OTII cells were sorted from spleens of donor mice and transferred intravenously into Rag2KOIl2fl/fl and Rag2KOIl2CD11c (a) or Cnb1CD11c and Cnb1fl/fl mice (b). After 24 h, mice were administered OVA protein antigen by daily oral gavage for 5 days. The frequencies of CD4+ T cells expressing FoxP3, IL-17, and IFNγ were examined in the mesenteric lymph node 7 days after adoptive cell transfer. Representative FACS plots of OTII donor CD4+ T cells are shown (left panels). Data represent the means ± standard deviation of two experiments (n = 1–2 mice/group). *P < 0.05 (two-tailed, unpaired Student’s t test)
Fig. 9
Fig. 9
Systemic and intestinal immune homeostasis in Il2CD11c and Il2CD4 mice. a RBC count and b total number of splenocytes and proportion of CD4+ T cells, FoxP3+ Treg cells, and B220+ B cells in spleens of Il2fl/fl, Il2CD11c, and Il2CD4 mice. Representative images of spleens are shown. Data represent the means ± standard error of 2–6 experiments (n = 2–3 mice/group per experiment, 6–13 weeks old). **P < 0.01, ***P < 0.001. c Representative images of H&E-stained colon sections (×4 magnification, scale bar 0.5 mm; ×10 magnification, scale bar 0.1 mm) from Il2CD11c, Il2CD4, and Il2KO mice. d Total LP-colon leukocyte number and percentage of total and activated (CD44highCD62L) CD4+ T cells, and B cells. e, f Percentage of IFNγ- and IL-17-producing CD4+ T cells, and FoxP3+ Treg cells obtained from the LP-colon of Il2fl/fl, Il2CD11c, Il2CD4, and Il2KO mice. Data represent the means ± standard error of 2–4 experiments (n = 2–3 mice/group per experiment, 9–13 weeks old). **P < 0.01, ***P < 0.001. LP lamina propria, RBC red blood cells

Similar articles

Cited by

References

    1. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 2015;12:720–727. doi: 10.1038/nrgastro.2015.150. - DOI - PubMed
    1. Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 2014;14:667–685. doi: 10.1038/nri3738. - DOI - PubMed
    1. Joeris T, Muller-Luda K, Agace WW, Mowat AM. Diversity and functions of intestinal mononuclear phagocytes. Mucosal Immunol. 2017;10:845–864. doi: 10.1038/mi.2017.22. - DOI - PubMed
    1. Fric J, et al. NFAT control of innate immunity. Blood. 2012;120:1380–1389. doi: 10.1182/blood-2012-02-404475. - DOI - PubMed
    1. Zelante T, et al. CD103(+) dendritic cells control Th17 cell function in the lung. Cell Rep. 2015;12:1789–1801. doi: 10.1016/j.celrep.2015.08.030. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources